Marshall Wace’s Sanaby Health Acquisition Corp. I Class A Common Stock SANB Stock Holding History

Marshall Wace’s Portfolio SANB Stock Details SANB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-628,774	Closed	-$6.37M	–	3872
2022 Q3	$6.37M	Hold	628,774	–	–	0.01%	1196
2022 Q2	$6.31M	Hold	628,774	–	–	0.01%	1184
2022 Q1	$6.29M	Hold	628,774	–	–	0.01%	1202
2021 Q4	$6.24M	Buy	+628,774	New	+$6.24M	0.01%	1195

Marshall Wace's SANB Position: Q4 2022 in Review

Marshall Wace sold out of Sanaby Health Acquisition Corp. I Class A Common Stock (SANB) in Q4 2022, closing a stake of 628,774 shares — an estimated $6.37M sold.

Marshall Wace first reported a position in SANB in Q4 2021 and held it in 4 quarters. The position peaked at $6.37M in Q3 2022. 0 funds tracked by Wall St. Rank hold SANB as of Q4 2022.

Marshall Wace reported no remaining Sanaby Health Acquisition Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Marshall Wace sold 628,774 Sanaby Health Acquisition Corp. I Class A Common Stock shares in Q4 2022, an estimated $6.37M.
Marshall Wace first reported a position in Sanaby Health Acquisition Corp. I Class A Common Stock in Q4 2021 and held it in 4 quarters.
Marshall Wace's Sanaby Health Acquisition Corp. I Class A Common Stock position peaked at $6.37M in Q3 2022.
0 funds tracked by Wall St. Rank held Sanaby Health Acquisition Corp. I Class A Common Stock as of Q4 2022.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.